Effects of 3T3 adipocytes on interleukin-6 expression and insulin signaling in L6 skeletal muscle cells

Biochemical and Biophysical Research Communications

Volumn 410, Issue 1, 2011, Pages 13-18

  Seyoum, B ^a   Fite, A ^a   Abou Samra, A B ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipocyte; Diabetes; IL 6; Skeletal muscle

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INSULIN; INTERLEUKIN 6; MESSENGER RNA; PROTEIN KINASE B;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DENSITY; CELL INFILTRATION; CELL INTERACTION; CLINICAL EXAMINATION; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN SENSITIVITY; MOUSE; MUSCLE CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

3T3 CELLS; ADIPOCYTES; ANIMALS; COCULTURE TECHNIQUES; INSULIN; INTERLEUKIN-6; MICE; MUSCLE FIBERS, SKELETAL; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS);

EID: 79959379975     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.073     Document Type: Article

References (31)

1. Dvorak R.V., DeNino W.F., Ades P.A., Poehlman E.T. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 1999, 48(11):2210-2214.
2. Stefan N., Kantartzis K., Machann J., et al. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 2008, 168(15):1609-1616.
3. Sell H., Dietze-Schroeder D., Eckel J. The adipocyte-myocyte axis in insulin resistance. Trends Endocrinol. Metab. 2006, 17(10):416-422.
4. Rajala M.W., Scherer P.E. Minireview: the adipocyte at the crossroads of energy homeostasis inflammation and atherosclerosis endocrinology 2003, 144(9):3765-3773.
5. Phillips D.I., Caddy S., Ilic V., et al. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism Aug 1996, 45(8):947-950.
6. Forouhi N.G., Jenkinson G., Thomas E.L., et al. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia Aug 1999, 42(8):932-935.
7. Perseghin G., Scifo P., F De Cobelli, et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999, 48(8):1600-1606.
8. Goodpaster B.H., He J., Watkins S., Kelley D.E. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J. Clin. Endocrinol. Metab. 2001, 86(12):5755-5761.
9. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAM 2001, 286(3):327-334.
10. Helge J.W., Stallknecht B., Pedersen B.K., Galbo H., Kiens B., Richter E.A. The effect of graded exercise on IL-6 release and glucose uptake in human skeletal muscle. J. Physiol. 2003, 546(Pt. 1):299-305.
11. King P.A., Betts J.J., Horton E.D., Horton E.S. Exercise, unlike insulin, promotes glucose transporter translocation in obese Zucker rat muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1993, 265(2):R447-452.
12. King P.A., Horton E.D., Hirshman M.F., Horton E.S. Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation. J. Clin. Invest. 1992, 90(4):1568-1575.
13. Zierath J.R., He L., Guma A., Odegoard Wahlstrom E., Klip A., Wallberg-Henriksson H. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 1996, 39(10):1180-1189.
14. Goodyear L.J., Giorgino F., Balon T.W., Condorelli G., Smith R.J. Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 1995, 268(5):E987-995.
15. Lee A.D., Hansen P.A., Holloszy J.O. Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. FEBS Lett. 1995, 361(1):51-54.
16. Yeh J.-I., Gulve E.A., Rameh L., Birnbaum M.J. The effects of Wortmannin on rat skeletal muscle. J. Biol. Chem. 1995, 270(5):2107-2111.
17. Yamashita A., Soga Y., Iwamoto Y., et al. Macrophage-adipocyte interaction marked interleukin-6 production by lipopolysaccharide[ast]. Obesity 2007, 15(11):2549-2552.
18. Kim H.J., Higashimori T., Park S.Y., et al. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 2004, 53(4):1060-1067.
19. Zhou L., Sell H., Eckardt K., Yang Z., Eckel J. Conditioned medium obtained from in vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes. FEBS Lett. 2007, 581(22):4303-4308.
20. Harkins J.M., Moustaid-Moussa N., Chung Y-J., et al. Expression of interleukin-6 Is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice. J. Nutr. 2004, 134(10):2673-2677.
21. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2001, 280(5):E745-E751.
22. Bastard J.P., Jardel C., Bruckert E., et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 2000, 85(9):3338-3342.
23. Bastard J.P., Maachi M., Van Nhieu J.T., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 2002, 87(5):2084-2089.
24. Pedersen B.K., Steensberg A., Fischer C., et al. The metabolic role of IL-6 produced during exercise is IL-6 an exercise factor?. Proc. Nutr. Soc. 2004, 63(2):263-267.
25. Langberg H., Olesen J.L., Gemmer C., Kjaer M. Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans. J. Physiol. 2002, 542(Pt. 3):985-990.
26. Langberg H., Olesen J.L., Gemmer C., Kjar M. Substantial elevation of interleukin-6 concentration in peritendinous tissue in contrast to muscle following prolonged exercise in humans. J. Physiol. 2002, 542(3):985-990.
27. Glund S., Deshmukh A., Long Y.C., et al. Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes 2007, 56(6):1630-1637.
28. Carey A.L., Steinberg G.R., Macaulay S.L., et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 2006, 55(10):2688-2697.
29. Senn J.J., Klover P.J., Nowak I.A., Mooney R.A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002, 51(12):3391-3399.
30. Rotter V., Nagaev I., Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is like IL-8 and tumor necrosis factor-alpha overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 2003, 278(46):45777-45784.
31. Mohamed-Ali V., Goodrick S., Rawesh A., et al. But not tumor necrosis factor-{alpha} in vivo. J. Clin. Endocrinol. Metab. 1997, 82(12):4196-4200.